DeepCure Competitors and Similar CompaniesClear all

DeepCure's competitors and similar companies include InSilico Medicine, Healx, BullFrog AI and GV20 Oncotherapy.

	DeepCure DeepCure is a company that specializes in AI-based drug discovery for small molecule therapeutics.	InSilico Medicine InSilico Medicine Hong Kong is a technology company that develops AI-based platforms for drug development and discovery.	Healx Healx is an AI technology company accelerating the discovery and development of rare disease treatments.	BullFrog AI BullFrog AI is a digital biopharma company providing an AI and machine learning platform for drug development.	GV20 Oncotherapy GV20 Oncotherapy is a company developing biotechnologies and drugs against cancer.
Founding Date	Founding Date 2018	Founding Date 2014	Founding Date 2014	Founding Date 2017	Founding Date 2016
Type	Type Private	Type Private	Type Private	Type Public	Type Private
Tags	Tags Technology artificial intelligence biotech drug development	Tags Technology artificial intelligence discovery platform drug development healthtech machine learning	Tags Technology artificial intelligence biotech drug development healthtech therapy	Tags Technology artificial intelligence biotech discovery platform drug development machine learning	Tags Technology artificial intelligence biotech drug development healthtech pharma
Locations	Locations Boston, US HQ	Locations Hong Kong, HK HQ New York, US	Locations Cambridge, GB HQ	Locations Gaithersburg, US HQ	Locations Cambridge, US HQ Shanghai, CN
Employees	Employees 35	Employees 2842% increase	Employees 683% decrease	Employees 2100% increase	Employees 22
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £300k (FY, 2021)	Revenue (est.) $116.7k (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods £120k (FY, 2021)	Cost of goods $94.8k (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit £180k (FY, 2021)	Gross profit $21.9k (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income (£15.7m) (FY, 2021)	Net income ($6.5m) (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 255m (almost 5 years ago)	Latest funding round $ 56m (over 6 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 306.3m	Total funding raised $ 66m	Total funding raised N/A	Total funding raised N/A